Pharma & Biotech

Shares of Capricor Therapeutics are undergoing a reassessment by market experts, reflecting a shift in sentiment. The biotech firm's stock,...

The investment thesis for pharmaceutical giant Novo Nordisk is undergoing a significant reassessment. While the company celebrates a key regulatory...

Entering the new year, BioNxt Solutions (BNXT) carries significant momentum, with investor focus shifting from near-term volatility to a clearly...

The new trading year has begun on a positive note for CureVac, with its shares posting significant gains. This upward...

Johnson & Johnson shares are trading near record highs, yet major institutional investors are sending mixed signals through their recent...

Redcare Pharmacy is entering 2026 under significant strain. The MDAX-listed company's shares have lost approximately half their value over the...

The telehealth provider Hims & Hers officially launched operations in Canada on December 4, 2025. This strategic move was executed...

Despite a challenging year for its share price, BioNTech concludes 2025 in a stronger strategic and financial position than market...

A wave of institutional investment and a strategic push to expedite a key drug approval are reinforcing the bullish narrative...

The German biotech firm BioNTech is decisively pivoting beyond its pandemic-era identity, placing a substantial strategic bet on mRNA oncology....